ProShares Ultra Nasdaq Biotechnology (BIB) Holdings → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free BIB Stock Alerts $54.47 -0.95 (-1.71%) (As of 05/10/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Top 50 BIB HoldingsRankCompanyCurrent PriceWeightShares Held1NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGN/A46.24%9,5502NASDAQ BIO INDEX SWAP BNPN/A36.61%7,5623NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAN/A18.85%3,8934NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEN/A14.21%2,9365AMGNAmgen$310.15-0.9%6.47%18,7856NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONALN/A6.40%1,321 Get the Latest News and Ratings for BIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 7REGNRegeneron Pharmaceuticals$973.80+0.6%5.64%5,3268VRTXVertex Pharmaceuticals$422.78+0.9%5.42%12,2269GILDGilead Sciences$65.96+2.1%5.11%71,34310NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAN/A5.04%1,04211MRNAModerna$117.31-4.4%3.47%25,09112NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLCN/A3.31%68313AZNAstraZeneca$77.18-0.6%3.23%38,23714BIIBBiogen$221.50-0.6%2.30%9,54515ALNYAlnylam Pharmaceuticals$150.47-0.6%1.39%8,27216ILMNIllumina$110.53-0.7%1.36%10,43317BMRNBioMarin Pharmaceutical$81.03-0.8%1.13%12,38718NBIXNeurocrine Biosciences$136.70-2.1%1.02%6,53719VTRSViatris$11.16-0.5%1.02%77,98020SNYSanofi$49.28+1.2%0.97%17,98821RPRXRoyalty Pharma$28.09+0.4%0.92%29,33422SRPTSarepta Therapeutics$131.82-0.4%0.91%6,16423UTHRUnited Therapeutics$264.27-0.7%0.90%3,09224ARGXargenx$374.63-2.1%0.88%2,04325INCYIncyte$53.06-0.8%0.88%14,74626MEDPMedpace$390.19-2.3%0.88%2,02127ROIVRoivant Sciences$11.13-1.1%0.67%52,91628BNTXBioNTech$91.67-0.4%0.65%6,35629ASNDAscendis Pharma A/S$133.46+0.2%0.57%3,77330PCVXVaxcyte$65.19-0.6%0.52%7,11631JAZZJazz Pharmaceuticals$109.63-3.1%0.50%4,09232BGNEBeiGene$161.13-4.5%0.49%2,71933CYTKCytokinetics$62.10-3.0%0.49%6,76134BPMCBlueprint Medicines$106.70-1.5%0.48%4,02235EXELExelixis$21.37-1.8%0.48%19,91136ITCIIntra-Cellular Therapies$64.96-0.9%0.48%6,36037RVMDRevolution Medicines$37.25-0.5%0.48%10,81738IBRXImmunityBio$8.12+0.7%0.44%43,84339IONSIonis Pharmaceuticals$39.08-1.0%0.44%9,57440APLSApellis Pharmaceuticals$41.99-1.2%0.42%7,921Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is.41HALOHalozyme Therapeutics$43.15-1.6%0.37%8,32642BBIOBridgeBio Pharma$29.10+1.3%0.36%11,54543CRSPCRISPR Therapeutics$51.17-4.4%0.33%5,27244KRYSKrystal Biotech$154.76-2.5%0.33%1,85645MDGLMadrigal Pharmaceuticals$205.25-0.8%0.33%1,30846ALPNAlpine Immune Sciences$64.94+0.2%0.31%4,30647IMVTImmunovant$29.39-1.0%0.30%9,54048NUVLNuvalent$65.48-3.0%0.30%3,85249ALKSAlkermes$24.05-0.9%0.29%10,97050IOVAIovance Biotherapeutics$10.97-18.4%0.28%18,341 Geographic ExposureUnited States82.7%Ireland0.9%Bermuda0.7%Canada0.5%Switzerland0.3%Netherlands0.2%Jersey0.1%Singapore0.1%Currency ExposureUSD91.9%Sector ExposureHealth Care57.4%Consumer Discretionary0.5%Energy0.2%Industry ExposureBiotechnology53.0%Health Care Equipment & Supplies1.9%Diversified Consumer Services1.1%Pharmaceuticals0.6%Distributors0.4%Renewable Energy0.2%SubIndustry ExposureBiotechnology50.8%Life Sciences Tools & Services2.7%Pharmaceuticals1.1%Renewable Energy Equipment0.2%Health Care Equipment0.1% Related Companies and Tools Related Companies: Principal Healthcare Innovators ETF Top Holdings Invesco Nasdaq Biotechnology ETF Top Holdings Invesco Dorsey Wright Healthcare Momentum ETF Top Holdings First Trust Nasdaq Pharmaceuticals ETF Top Holdings Horizon Kinetics Medical ETF Top Holdings JPMorgan Healthcare Leaders ETF Top Holdings ProShares UltraShort Nasdaq Biotechnology Top Holdings Invesco S&P SmallCap Health Care ETF Top Holdings VanEck Biotech ETF Top Holdings VanEck Pharmaceutical ETF Top Holdings This page (NASDAQ:BIB) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.